Morgan Stanley (NYSE:MS)
$ 117.81 1.67 (1.44%) Market Cap: 189.80 Bil Enterprise Value: 455.16 Bil PE Ratio: 17.93 PB Ratio: 2.02 GF Score: 81/100

Arcus Biosciences Inc at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 03:10PM GMT
Release Date Price: $43.58 (+1.09%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

All right. Thanks, everyone, for being here. We're going to get started. So I'm Vikram Purohit. I'm one of the biotech analysts here at Morgan Stanley. And before we get into it with Arcus, just need to let everyone know that for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures.

So with that, happy to have with me on the stage, Arcus Biosciences CEO, Terry Rosen. Terry, welcome.

Terry J. Rosen
Arcus Biosciences, Inc. - Co-Founder, Chairman & CEO

Thank you. Happy to be here.

Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst

Yes. Happy to have you.

Terry J. Rosen;Vikram Purohit
Arcus Biosciences, Inc. - Co-Founder, Chairman & CEO;Morgan Stanley, Research

Appreciate it.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot